Global hysteroscopy market was valued at USD 383 billion in 2020. It is projected to grow at 6.7% compound annual growth rate (CAGR), between 2021 and 2028. Market growth is driven by the increasing incidence of gynecological conditions such as uterine abnormalities and abnormal uterine bleeding. The market is also being driven by technological advances and the increasing use of minimally invasive surgery over traditional methods. The market has seen significant changes due to the COVID-19 epidemic. Patients with other diseases are not receiving adequate care due to the unprecedented rise in COVID-19 cases worldwide.
Hospitals tended to prioritize emergency procedures and delayed/postponed elective surgeries. This led to patients waiting in line for months for their surgery. CovidSurg Collaborative Study 2020 projected that approximately 28.4 Million elective surgeries, which includes 81.7% of benign surgeries, would be canceled or delayed in 2020 due to disruptions in medical services. Many elective procedures can now be resumed with no restrictions. The market will recover slowly, however.
Uterine cancer is on the rise, which has led to an increase in hysteroscopy procedures. This has accelerated market growth. Uterine cancer is a very common gynecological disorder worldwide and is increasing at an alarming rate. The increasing prevalence of obesity is driving this increase in uterine cancer risk. According to the American Cancer Society (ACS), 66,570 new cases of uterine cancer are expected to be diagnosed by 2021. Uterine cancer is expected to cause around 12,940 deaths in 2021.
Minimally invasive surgery is gaining popularity due to the lower risk. These procedures are highly popular because they require minimal incisions, which reduce pain after surgery and speed up recovery. Hysteroscopy, for instance, is associated with fewer hospitalizations, quicker recovery and lower blood loss. Hysteroscopy also causes less abdominal pain after surgery and a smaller wound. Market growth is expected to be boosted by a rise in patients' preference for minimally invasive treatments and the benefits these techniques offer.
Many key players have invested in R&D to develop innovative, minimally-invasive surgical instruments. Many technologically advanced hysteroscopes have been introduced to the market recently and can be tailored according to the procedure. Meditrina, Inc., for instance, launched the Aveta Opal disposable hysteroscope and Aveta Auto resecting device in July 2021. The firm will be able to expand its portfolio of hysteroscopic tissue-resection products and strengthen its market position with this new launch.
Hologic, Inc., CooperSurgical, Inc., Stryker Corp., Stryker Corp., Karl Storz GmbH, Medtronic, Delmont Imaging, and Johnson and Johnson Services, Inc. are all involved in extensive R&D to produce innovative products and continue to push the boundaries of technology. Delmont Imaging's imaging solution imagyn is an advanced hysteroscopy data management application. This allows you to monitor hysteroscopy examinations directly from your iPad Pro via secure and private Wi-Fi. VirtaMed created a mixed reality platform that is authorized for hysteroscopy as well as gynecological and laparoscopy training. These developments will likely further increase market growth.
The market is segmented by end use into hospitals, clinics and Ambulatory Surgery Centers. In 2020, the hospitals segment had the highest revenue share at 52%. This was due to a significant increase in patients for gynecological services. Hospitals can also handle any emergency that might arise after or during surgery. Hospitals offer many treatment options which will continue to drive this segment in the future. According to the NCBI, approximately 30,000 myomectomies for leiomyomata in the U.S. are performed each year. Hospitals are also the main health system in most countries. Therefore, there is a higher number of hysteroscopy procedures performed at hospitals than in other healthcare settings.
The segment ASCs is expected to show the highest CAGR at 7.00% over the forecast period. The segment could see a rise in outpatient procedures, which might increase the use of hysteroscopy procedures at ASCs. Outpatient (ambulatory hysteroscopy) is performed outside of a hospital in a well-equipped and staffed treatment area. This allows for patient comfort and decreases the time required to perform diagnostic hysteroscopy. It is also cost-effective and efficient for surgeons and patients, as it includes an operating room. The accuracy and patient acceptance of ambulatory hysteroscopy has been comparable to that inpatient procedure. Therefore, ambulatory is rapidly becoming a popular option in gynecological practice.
North America was the dominant market in global sales with a revenue share exceeding 38% in 2020. This will continue to grow at a steady CAGR of 3% from 2021-2028. This is due to favorable government regulations and reimbursement policies, the presence key market players, growing approvals & commercializations of products, as well as high awareness about the availability of diagnostic tests. Market growth is also due to the increasing demand for minimally invasive procedures, and increased investments in R&D of gynecological system. In August 2018, UVision360 approved the Luminelle DTx Hysteroscopy system by UVision360, which can be used for both hysteroscopy or cystoscopy. This system allows doctors to perform in-office procedures such as biopsy and detect abnormal tissue growth. This region is seeing significant market growth due to the availability of healthcare technologies, strong distribution channels, as well as competition among major players in product innovation.
Asia Pacific will be the fastest-growing region market over the forecast period. There are significant growth opportunities due to the large patient base and growing demand for cost-effective, technologically advanced healthcare solutions. The market is also expected to see a rise in clinical trials and large R&D investments from global market players in order to access untapped markets in Asia Pacific. This is due to the low cost of services. The market will see a rise in the incidence of women's health issues and consequently, an increase in the number of surgeries over the forecast period. South Korea and Singapore are two of the Asia Pacific's emerging economies. The region's growth will be driven by technology advancements, increased investments, improved reimbursement scenarios, and growing medical tourists.
To strengthen their position in the global market, key players participate in strategies such as mergers and acquisitions, partnerships, new product launches, and partnership formations. CooperSurgical, Inc. purchased AEGEA Medical in February 2021. This acquisition will allow the company to expand its product line in women's health.
Hologic, Inc. introduced the Fluent Fluid Management System, which is a CE-marked European system, in January 2021. This system helps maintain consistent intracavity pressure, and uterine dilation. The company was able to strengthen its market position as well as expand its hysteroscopy product range with this launch. The following are some of the most prominent players in global hysteroscopy market:
Medtronic
Stryker Corp.
Hologic, Inc.
KARL STORZ SE & Co. KG
Medical Devices Business Services, Inc.
Olympus Corp.
Delmont Imaging
B. Braun Melsungen AG
Richard Wolf GmbH
CooperCompanies
Maxer Endoscopy GmbH
Boston Scientific Corp.
MedGyn Products, Inc.
Lina Medical APS
Luminelle
Meditrina, Inc.
Up Market Research published a new report titled “Hysteroscopy Procedures Market research report which is segmented by End Use (Hospitals, Ambulatory Surgical Centers, Clinics), By Players/Companies Boston Scientific Corp, Medical Devices Business Services Inc (Ethicon Inc), Meditrina Inc (Aveta), Luminelle, Hologic Inc, MedGyn Products Inc, B Braun Melsungen AG, Stryker Corp, Richard Wolf GmbH, KARL STORZ SE & Co KG, Maxer Endoscopy GmbH, Delmont Imaging, Lina Medical APS, Olympus Corp, Medtronic, CooperCompanies”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Hysteroscopy Procedures Market Research Report |
By End Use | Hospitals, Ambulatory Surgical Centers, Clinics |
By Companies | Boston Scientific Corp, Medical Devices Business Services Inc (Ethicon Inc), Meditrina Inc (Aveta), Luminelle, Hologic Inc, MedGyn Products Inc, B Braun Melsungen AG, Stryker Corp, Richard Wolf GmbH, KARL STORZ SE & Co KG, Maxer Endoscopy GmbH, Delmont Imaging, Lina Medical APS, Olympus Corp, Medtronic, CooperCompanies |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 219 |
Number of Tables & Figures | 154 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by End Use (Hospitals, Ambulatory Surgical Centers, Clinics).
Hysteroscopy Procedures Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Hysteroscopy Procedures Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Hysteroscopy Procedures Market Report:
Some other reports from this category!